Anti-anthrax monoclonal antibodies (IQ Therapeutics)

N/A

Report date: 2022/03/17 11:31:39

Base Information

Drug NameAnti-anthrax monoclonal antibodies (IQ Therapeutics)
Drug Alias Name抗炭疽单克隆抗体（IQ Therapeutics）anti-PAanti-LFIQNLF-1IQ-NPA +[8] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAntrax lethal toxin inhibitors
TargetsAntrax lethal toxin
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIq Corp
China Registration ClassN/A

Develop Information

Active CompaniesIq Corp
Inactive CompaniesN/A
Active IndicationsAnthrax
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A